Peking Union Medical College Hospital: Rectal Neoplasms trials

The registry lists 13 Rectal Neoplasms studies with Peking Union Medical College Hospital as lead sponsor. 8 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 4Phase 3 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Randomized Controlled Trial of the SurgDiff Model for Predicting Surgical Difficulty to Help Choose Approach in Mid-Low Rectal CancerNot yet recruitingNCT07761169Not applicable
• Efficacy and Safety of Trastuzumab Biosimilars and Pertuzumab Biosimilars Combined With Chemotherapy for Neoadjuvant Treatment of Patients With Locally Advanced HER2-positive Rectal CancerRecruitingNCT07108127Phase 2
• Application of PET/MRI in the Evaluation of the Efficacy of Neoadjuvant Therapy for Locally Advanced Rectal CancerRecruitingNCT06653452Not applicable
• Reasons for Non-reversal of Temporary Stomas After Surgeries of Mid-low Rectal Cancer （NORESTO Study）RecruitingNCT06194708
• PTC Drug Sensitivity Detection to Guide Postoperative Adjuvant of Colorectal CancerRecruitingNCT05978349Not applicable
• Online Adaptive Radiation Therapy for Rectal CancerNot yet recruitingNCT05911789Phase 1/2
• Choice of the Optimal Treatment Strategies for Mid-low REctal CancerRecruitingNCT05871762
• Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal CancerRecruitingNCT05601505Phase 2
• TIME in Immunotherapy Combined With nCRT for Rectal CancerActive, not recruitingNCT05507112Phase 2
• Virtual Reality Videos in Improving Bowel Preparation Quality of ColonoscopyStatus unknownNCT03667911Not applicable
• Removal Time of Urinary Catheter After Laparoscopic Anterior Resection of the RectumStatus unknownNCT03065855Not applicable
• Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.Status unknownNCT03042000Not applicable
• Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal CancerStatus unknownNCT03038217Phase 3